Stock

Nasdaq:

DEPO

Price:

2.81 +0.02

Volume:

109,731

20 minute delay

In The News

July 29, 2010 Depomed to Announce Second Quarter 2010 Financial Results on August 5, 2010

June 28, 2010 Depomed Announces Receipt of a $10 Million Milestone Payment for DM-1796

June 28, 2010 New Clinical Study Shows Patients With Type 2 Diabetes May Be Able to Tolerate Higher Doses of Metformin Using GLUMETZA

June 7, 2010 Depomed Announces Acceptance of New Drug Application for Investigational Postherpetic Neuralgia Treatment DM-1796

May 4, 2010 Depomed to Present at the 9th Annual JMP Securities Research Conference